InvestSMART

Nova Eye Medical Limited (ASX: EYE) - Announcements

- Current share price for EYE : $0.135

ASX company news and announcements for Nova Eye Medical Limited (EYE) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Nova Eye Medical Limited (EYE) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Nova Eye Medical Limited (EYE), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Nova Eye Medical Limited (EYE)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$38 Appendix 3Z Coupe 30 Oct 2026 10:43AM $0.145 $0.135 fallen by 6.90%
$38 EYE AGM 2026 Meeting Results 29 Oct 2026 4:09PM $0.150 $0.135 fallen by 10%
$38 AGM 2026 Presentation 29 Oct 2026 10:05AM $0.145 $0.135 fallen by 6.90%
$38 AGM 2026 Chairmans Address 29 Oct 2026 10:01AM $0.145 $0.135 fallen by 6.90%
$38 Quarterly Activities/Appendix 4C Cash Flow Report 27 Oct 2026 12:59PM $0.150 $0.135 fallen by 10%
$38 Investor Webinar Monday 2 November @ 11.30 AEDT 26 Oct 2026 5:00PM $0.150 $0.135 fallen by 10%
$38 Director Resignation 23 Oct 2026 12:08PM $0.150 $0.135 fallen by 10%
$38 Change of Registry Address 23 Oct 2026 10:19AM $0.155 $0.135 fallen by 12.90%
$38 Notice of General Meeting/Proxy Form 29 Sep 2026 4:11PM $0.135 $0.135 fallen by 0%
$38 Cleansing Notice 22 Sep 2026 9:13AM $0.135 $0.135 fallen by 0%
$38 Application for quotation of securities - EYE 22 Sep 2026 9:11AM $0.135 $0.135 fallen by 0%
$38 Proposed issue of securities - EYE 21 Sep 2026 9:09AM $0.135 $0.135 fallen by 0%
$38 AGM date and closing date for Director Nominations 3 Sep 2026 4:55PM $0.135 $0.135 fallen by 0%
$38 Appendix 3 Y T A Spurling 28 Aug 2026 3:21PM $0.138 $0.135 fallen by 1.82%
$38 Appendix 4G and Corporate Governance Statement 26 Aug 2026 5:31PM $0.143 $0.135 fallen by 5.26%
$38 Full Year Financial Results 26 Aug 2026 5:04PM $0.143 $0.135 fallen by 5.26%
$38 Appendix 4E and Annual Report 26 Aug 2026 4:55PM $0.143 $0.135 fallen by 5.26%
$38 Notification of cessation of securities - EYE 5 Aug 2026 12:41PM $0.140 $0.135 fallen by 3.57%
$38 Investor Webinar Tuesday 4 August 2026 @ 11.30 AEST 29 Jul 2026 11:10AM $0.125 $0.135 risen by 8%
$38 Quarterly Activities/Appendix 4C Cash Flow Report 29 Jul 2026 11:03AM $0.120 $0.135 risen by 12.50%
$38 Application for quotation of securities - EYE 10 Jul 2026 2:39PM $0.115 $0.135 risen by 17.39%
$38 Notification of cessation of securities - EYE 25 Jun 2026 2:55PM $0.105 $0.135 risen by 28.57%
$38 Notification of cessation of securities - EYE 25 Jun 2026 2:49PM $0.105 $0.135 risen by 28.57%
$38 Notification regarding unquoted securities - EYE 6 May 2026 3:04PM $0.125 $0.135 risen by 8%
$38 Application for quotation of securities - EYE 6 May 2026 3:02PM $0.125 $0.135 risen by 8%

1 - 25 of 369 results

Page 1 of 15

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.